Get the Stockscreener App
1.9913
0.99%
-0.0287
Whitehawk Therapeutics Inc stock is traded at $1.9913, with a volume of 1,506.
It is down -0.99% in the last 24 hours and up +0.50% over the past month.
Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.
See More
Previous Close:
$2.02
Open:
$2.02
24h Volume:
1,506
Relative Volume:
0.01
Market Cap:
$94.26M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-6.98%
1M Performance:
+0.50%
6M Performance:
+21.95%
1Y Performance:
+0.00%
1-Day Range:
$2.00
$2.02
1-Week Range:
$2.00
$2.29
52-Week Range:
$1.39
$2.29
Whitehawk Therapeutics Inc Stock (WHWK) Company Profile
Name
Whitehawk Therapeutics Inc
Sector
Industry
Phone
551-321-2234
Address
2 HEADQUARTERS PLAZA, MORRISTOWN
Compare WHWK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WHWK
Whitehawk Therapeutics Inc
|
2.00 | 95.20M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
405.64 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.22 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
542.01 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
795.45 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
326.40 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Whitehawk Therapeutics Inc Stock (WHWK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-27-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-21-24 | Downgrade | Jefferies | Buy → Hold |
| Aug-21-24 | Downgrade | TD Cowen | Buy → Hold |
| Dec-15-23 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jan-11-22 | Initiated | Jefferies | Buy |
| Oct-01-21 | Initiated | Cowen | Outperform |
| Sep-14-21 | Initiated | Ladenburg Thalmann | Buy |
| Sep-08-21 | Initiated | Piper Sandler | Overweight |
View All
Whitehawk Therapeutics Inc Stock (WHWK) Latest News
What to expect from Whitehawk Therapeutics Inc. in the next 30 daysMarket Weekly Review & Safe Entry Momentum Tips - newser.com
Key resistance and support levels for Whitehawk Therapeutics Inc.July 2025 WrapUp & Low Volatility Stock Suggestions - newser.com
Will a bounce in Whitehawk Therapeutics Inc. offer an exitJuly 2025 News Drivers & Intraday High Probability Setup Alerts - newser.com
Whitehawk Therapeutics (NASDAQ:WHWK) Raised to Hold at Zacks Research - MarketBeat
Quantitative breakdown of Whitehawk Therapeutics Inc. recent moveOptions Play & Low Volatility Stock Recommendations - newser.com
Is Whitehawk Therapeutics Inc. reversing from oversold territoryCEO Change & Safe Capital Preservation Plans - newser.com
How analysts rate Whitehawk Therapeutics Inc. stock todayQuarterly Growth Report & Long-Term Capital Growth Ideas - newser.com
Is Whitehawk Therapeutics Inc. showing signs of accumulationJuly 2025 Drop Watch & Capital Efficient Trade Techniques - newser.com
Comparing Whitehawk Therapeutics Inc. in custom built stock radars2025 Momentum Check & AI Enhanced Execution Alerts - newser.com
Whitehawk Therapeutics' (WHWK) Sell (E+) Rating Reaffirmed at Weiss Ratings - MarketBeat
Whitehawk Therapeutics, Inc.'s (NASDAQ:WHWK) large hedge funds owners must be happy as stock continues to impress, up 17% over the past week - simplywall.st
Is Whitehawk Therapeutics Inc. stock safe for conservative investors2025 AllTime Highs & Reliable Intraday Trade Alerts - newser.com
How to read the order book for Whitehawk Therapeutics Inc.2025 Risk Factors & Growth-Oriented Investment Plans - newser.com
Why Whitehawk Therapeutics Inc. (3350) stock attracts HNW investors2025 EndofYear Setup & Long Hold Capital Preservation Tips - newser.com
Will Whitehawk Therapeutics Inc. (3350) stock outperform small cap peersAnalyst Upgrade & Reliable Intraday Trade Alerts - newser.com
Why Whitehawk Therapeutics Inc. stock is trending among retail traders2025 Dividend Review & Smart Allocation Stock Tips - newser.com
Using economic indicators to assess Whitehawk Therapeutics Inc. potentialTrade Risk Assessment & Low Risk High Win Rate Picks - newser.com
Is Whitehawk Therapeutics Inc. forming a reversal patternJuly 2025 Momentum & Fast Entry High Yield Stock Tips - newser.com
Is Whitehawk Therapeutics Inc. (3350) stock positioned for secular growthJuly 2025 Drop Watch & Fast Entry High Yield Stock Tips - newser.com
Analyzing Whitehawk Therapeutics Inc. with risk reward ratio chartsJuly 2025 Gainers & Long-Term Safe Investment Ideas - newser.com
Whitehawk Therapeutics Inc Stock Analysis and ForecastLow Risk Investment Ideas & Exceptional Capital Trading - earlytimes.in
Whitehawk Therapeutics Inc Stock (WHWK) Financials Data
There is no financial data for Whitehawk Therapeutics Inc (WHWK). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Whitehawk Therapeutics Inc Stock (WHWK) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Giacobello Scott M. | CHIEF FINANCIAL OFFICER |
Mar 03 '25 |
Sale |
2.35 |
2,806 |
6,594 |
23,944 |
| Lennon David James | CHIEF EXECUTIVE OFFICER |
Mar 03 '25 |
Sale |
2.35 |
5,690 |
13,372 |
33,429 |
2.36%
0.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):